Navigation Links
ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
Date:2/25/2008

mmune product market and expand on our existing revenue base," commented Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic.

More about Hepatitis B

HB, hepatitis B IVIG is primarily used in preventing reinfection with hepatitis B in HBV positive liver transplant patients. It is also used in the treatment of acute exposure to hepatitis B following acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg positive persons, and household exposure of infants to persons with acute hepatitis B virus infection. The groups usually considered at risk are hepatitis B researchers and workers, and many health care professionals. This group is estimated to lead to a demand for 45,000 doses per year of hepatitis B immune globulin. Pricing varies, but a reasonable rule of thumb is $900 per treatment. The market hepatitis B immune globulin in the U.S. is estimated $42 M in 2005. This should grow at a 10% AAGR to $67.6 M by 2010. (The Blood Industry, Copyright (C) Business Communications Co., Inc., Norwalk, CT USA, Web: http://www.bccresearch.com)

More about Kedrion S.p.A.

Kedrion is a biopharmaceutical company specializing in the development, production and distribution of plasma-derived products. In Italy, Kedrion is the main reference point for the National Health Service as regards the production of plasma-derived drugs. Moreover, its skills are also put to use in strategic partnerships with overseas health services. Kedrion is present in over 40 countries, and is in 6th place in the world for volume of fractionated plasma and 7th for sales. The quality of its products, its continuous commitment to research and development, its consistent industrial capacity and its consolidated presence on the national and international market are the company's main areas of competitiveness.

Kedrion is located in Caste
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
3. ProMetic provides business update - Over $35 million worth of business secured in January
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... ... Vestara announced today a strategic agreement with leading contract services ... Consortium (UHC) and nearly 14,000 members of Provista, LLC with the ... network includes acute hospitals and systems, academic medical centers, ambulatory care ...
... , AIX-EN-PROVENCE, France, Aug. 25 ... from the FDA for its Aixplorer(TM) ultrasound system and will ... States. Aixplorer is the only commercially available system of ... between conventional longitudinal waves and shear waves in tissue. ...
... NEW YORK, Aug. 25 Beth R. Jacobson (formerly Beth ... CELG ), under the claims of "misappropriation of an ... (THALOMID(R) and REVLIMID(R)) for the treatment of multiple myeloma. ... novel idea for treating multiple myeloma with thalidomide and is ...
Cached Biology Technology:Vestara Announces Strategic Agreement with Leading Contract Services Company Novation 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 4
(Date:4/24/2014)... West Virginia University researchers are the first to sequence ... view of eagle features that could lead to more ... question long-held assumptions about golden eagle vision, indicating that ... light as previously thought. The genome also suggests that ... than researchers realized. , Additionally, the genome provides ...
(Date:4/24/2014)... NY, April 24, 2014D-ribose is a commercially important ... and as a starting compound for synthesizing riboflavin ... Escherichia coli to increase the bacteria,s ability ... achieving more efficient industrial-scale production of this valuable ... Industrial Biotechnology , a peer-reviewed journal from Mary ...
(Date:4/24/2014)... a simple and cheap way of making a high-powered ... high-resolution microscope. , Costing less than a cent, the ... developing countries and remote areas. , The lens fabrication ... Australian National University (ANU) Research School of Engineering, who ... of Medical Research to find ways to transform the ...
Breaking Biology News(10 mins):Genome yields insights into golden eagle vision, smell 2Droplet lens 2
... at the Research School of Chemistry at The Australian National ... more than 20 years scientists have tried in vain to ... cells that are about to divide. , The research findings ... , In all cells, DNA is copied by a large ...
... to avoid smiling in public in order to hide their ... costly treatment options, such as veneers, crowns and bonding, served ... such stains and boost their self-esteem. , However, Kim ... how a new tooth whitening procedure he used on a ...
... have discovered the genetic controls which cause trees to ... well as the mechanism that causes them to begin ... understanding the basic genetics of tree growth. , The ... of Agricultural Sciences, Oregon State University and two other ...
Cached Biology News:ANU scientists crack DNA replication mystery 2Tetracycline plus teeth equal gray smile 2Tetracycline plus teeth equal gray smile 3Discovery may speed forest biotechnology 2Discovery may speed forest biotechnology 3